Expression of organic anion-transporting polypeptides 1B3, 1B1, and 1A2 in human pancreatic cancer reveals a new class of potential therapeutic targets

OncoTargets and Therapy

Volumn 4, Issue , 2011, Pages 27-32

  Kounnis, Valentinos ^a   Ioachim, Elli ^b   Svoboda, Martin ^c   Tzakos, Andreas ^a   Sainis, Ioannis ^a   Thalhammer, Theresia ^c   Steiner, Georg ^d   Briasoulis, Evangelos ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b G HATZIKOSTA GENERAL HOSPITAL   (Greece)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d TissueGnostics GmbH   (Austria)

Author keywords

Organic anion transporting polypeptides; Targeted therapy; Transporter

Indexed keywords

MESSENGER RNA; ORGANIC ANION TRANSPORTER 1; ORGANIC ANION TRANSPORTER 1A2; ORGANIC ANION TRANSPORTER 1B1; ORGANIC ANION TRANSPORTER 1B3; UNCLASSIFIED DRUG;

AGED; ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; CRYSTAL STRUCTURE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MALE; PANCREAS BIOPSY; PANCREAS CANCER; PROTEIN EXPRESSION; PROTEIN STRUCTURE;

EID: 79955494794     PISSN: 11786930     EISSN: None     Source Type: Journal    
DOI: 10.2147/OTT.S16706     Document Type: Article

References (26)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277-300.
2. Shaib Y, Davila J, Naumann C, El-Serag H. The impact of curative intent surgery on the survival of pancreatic cancer patients: a US populationbased study. Am J Gastroenterol. 2007;102(7):1377-1382.
3. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010;46(4):765-781.
4. Hidalgo M. Pancreatic cancer. New Engl J Med. 2010;362(17): 1605-1617.
5. Berlin JD, Catalano P, Thomas JP, Kugler JW, Haller DG, Benson AB. Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group trial E2297. J Clin Oncol. 2002; 20(15):3270-3275.
6. Burris H, Moore M, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol. 1997;15(6): 2403-2413.
7. Briasoulis E, Pavlidis N, Terret C, et al. Glufosfamide administered using a 1-hour infusion given as first-line treatment for advanced pancreatic cancer. A phase II trial of the EORTC-new drug development group. Eur J Cancer. 2003;39(16):2334-2340.
8. Kullak-Ublick GA, Hagenbuch B, Stieger B, et al. Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver. Gastroenterology. 1995;109(4):1274-1282.
9. Sainis I, Fokas D, Vareli K, Tzakos A, Kounnis V, Briasoulis E. Cyanobacterial cyclopeptides as lead compounds to novel targeted cancer drugs. Marine Drugs. 2010;8(3):629-657.
10. Abe T, Unno M, Onogawa T, et al. LST-2, A human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers. Gastroenterology. 2001;120(7):1689-1699.
11. Steiner GE, Ecker RC, Kramer G, Stockenhuber F, Marberger MJ. Automated data acquisition by confocal laser scanning microscopy and image analysis of triple stained immunofluorescent leukocytes in tissue. J Immunol Methods. 2000;237(1-2):39-50.
12. Kramer G, Steiner GE, Neumayer C, et al. Over-expression of anti-CD75 reactive proteins on distal and collecting renal tubular epithelial cells in calcium-oxalate stone-forming kidneys in Egypt. BJU Int. 2004;93(6):822-826.
13. Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol. 2007;8(2):R19.
14. Fountzilas G, Gratzner H, Lim LO, Yunis AA. Comparative effects of selected drug combinations on the growth of a human pancreatic carcinoma cell line (MIA PaCa-2). J Natl Cancer Inst. 1986;76(1): 37-43.
15. Tan MH, Nowak NJ, Loor R, et al. Characterization of a new primary human pancreatic tumor line. Cancer Invest. 1986;4(1):15-23.
16. Braun MM, Farag-El-Massah S, Xu K, Coté TR. Emergence of orphan drugs in the United States: a quantitative assessment of the first 25 years. Nat Rev Drug Discov. 2010;9(7):519-522.
17. Bronger H, Konig J, Kopplow K, et al. ABCC drug efflux pumps and organic anion uptake transporters in human gliomas and the blood-tumor barrier. Cancer Res. 2005;65(24):11419-11428.
18. Liedauer R, Svoboda M, Wlcek K, et al. Different expression patterns of organic anion transporting polypeptides in osteosarcomas, bone metastases and aneurysmal bone cysts. Oncol Rep. 2009;22(6): 1485-1492.
19. Muto M, Onogawa T, Suzuki T, et al. Human liver-specific organic anion transporter-2 is a potent prognostic factor for human breast carcinoma. Cancer Sci. 2007;98(10):1570-1576.
20. Cui Y, König J, Leier I, Buchholz U, Keppler D. Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. J Biol Chem. 2001;276(13):9626-9630.
21. Fischer WJ, Altheimer S, Cattori V, Meier PJ, Dietrich DR, Hagenbuch B. Organic anion transporting polypeptides expressed in liver and brain mediate uptake of microcystin. Toxicol Appl Pharmacol. 2005;203(3):257-263.
22. Bouaïcha N, Maatouk I. Microcystin-LR and nodularin induce intracellular glutathione alteration, reactive oxygen species production and lipid peroxidation in primary cultured rat hepatocytes. Toxicol Lett. 2004;148(1-2):53-63.
23. Kounnis V, Ioachim E, Svoboda M, et al. Investigations on organic anion-transporting polypeptides 1A2, 1B1 and 1B3 in colon cancer as potential targets for cancer therapy. EJC. 2010;S8(7):112.
24. Huang Y, Lemieux MJ, Song J, Auer M, Wang D-N. Structure and mechanism of the glycerol-3-phosphate transporter from Escherichia coli. Science. 2003;301(5633):616-620.
25. Eswar N, Webb B, Marti-Renom MA, et al. Comparative Protein Structure Modeling Using MODELLER. John Wiley & Sons, Inc; 2001.
26. Gui C, Hagenbuch B. Amino acid residues in transmembrane domain 10 of organic anion transporting polypeptide 1B3 are critical for cholecystokinin octapeptide transport. Biochemistry. 2008;47(35): 9090-9097.